Award recordCONTRACT

CSL BEHRING L.L.C.

PIID VA671A20009· VHA· 674-TEMPLE· 6505 · DRUGS AND BIOLOGICALS· FY2012· $419,345 net obligations· UEI H3WKVE9VBLY3· PA

Description

IMMUNE GLOBULIN

First action · last action
2011-10-01 · 2013-04-25
Transactions
3
First transaction's obligation
$408,794
Base + all options value (sum of deltas)
$419,345
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5045B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$420,664$0Base award · 2011-10-01 · this action $408,794 · running total $408,794Modification 1 · 2012-02-07 · this action $11,869 · running total $420,664Modification P00002 · 2013-04-25 · this action -$1,319 · running total $419,345
  • Base2011-10-01+$408,794= $408,794
  • Mod 12012-02-07+$11,869= $420,664
  • Mod P000022013-04-25-$1,319= $419,345
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2011-10-01+$408,794$408,794IMMUNE GLOBULIN
Mod 1· CHANGE ORDER2012-02-07+$11,869$420,664IMMUNE GLOBULIN
Mod P00002· FUNDING ONLY ACTION2013-04-25−$1,319$419,345IMMUNE GLOBULIN

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H3WKVE9VBLY3)

AwardOffice · PSC / listingNet obligationsFY
36C24826F0207248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$183,903FY2026
36C24826F0187248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$36,781FY2026
36C25226F0318252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$85,484FY2026
36C24826F0091248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$147,122FY2026
36C24826F0037248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$124,240FY2026
36C24824F0327248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$391,583FY2024

Other recipients under 6505 from 674-TEMPLE (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25714J2144LANTHEUS MEDICAL IMAGING, INC.674-TEMPLE$4,416FY2014
VA25713P2643PARTSSOURCE INC674-TEMPLE$5,000FY2013
VA25713F0032ACTELION PHARMACEUTICALS US, INC.674-TEMPLE$4,293FY2013
VA25713F0018ACTELION PHARMACEUTICALS US, INC.674-TEMPLE$4,293FY2013
VA25712C0111CARDINAL HEALTH 414, LLC674-TEMPLE$369,880FY2013

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA671A20009_3600_V797P5045B_3600 · retrieved 2026-09-26.